£77.58

Springer Systemic Radiotherapy with Monoclonal Antibodies: Options and Problems: 141 (Recent Results in Cancer Research, 141)

Price data last checked 49 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£78 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 42 days · 42 data points (no recent data)

Historical
Generating forecast…
£77.60 £77.58 £77.58 £77.59 £77.59 £77.60 £77.60 23 April 2026 03 May 2026 13 May 2026 23 May 2026 03 June 2026

Price Distribution

Price distribution over 42 days • 1 price levels

Days at Price
42 days 0 11 21 32 42 £78 Days at Price

Price Analysis

Most common price: £78 (42 days, 100.0%)

Price range: £78 - £78

Price levels: 1 different prices over 42 days

Description

Almost a century ago Paul Ehrlich introduced the "magic bullet" concept of targeting therapeutic agents to specific tissues in order to reduce systemic toxicity. Due to the advances in hybridoma technology in the 1980s, monoclonal antibodies (MAbs) with their exquisite affinity to tumor antigens have become powerful tools in the treatment of cancer, especially when linked to therapeutic agents such as radionuclides, drugs, toxins, or enzymes. It can now be expected that such agents will lead to new cancer treatments with high therapeutic success rates. However, there are major problems in developing this therapeutic concept to a routine treatment modality. This is partly due to factors such as heterogenous distribution of tumor antigens, insufficient blood supply of tumors, high interstitial pressure, and the large interstitial space that antibodies have to traverse. This book is focused on the development in radio immunotherapy (RIT) using radio labeled monoclonal antibodies as tumoritoxic agents. This area of research has attracted the interest of clinicians and scientists from many different disciplines. It is now clear that the full potential of RIT can only be realized through the concerted efforts of laboratory scientists (molecular biologists, cell physiologists, chemists, radiation physicists, and biologists) and cancer clinicians in nuclear medicine, radiooncology, and internal oncology. Review "a timely and deliberately provocative new impetus to this long overdue discussion of promising, selective cancer treatment." Jnl. of the National Cancer Institute

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
14 December 2011
Listed Since
13 July 2012

Barcode

No barcode data available

Similar Products You Might Like

Radiolabeled Monoclonal Antibodies for Imaging and Therapy: 152 (NATO Science Series A:, 152)
87% match

Radiolabeled Monoclonal Antibodies for Imaging and Therapy: 152 (NATO Science Series A:, 152)

Springer

£128.93 01 Jun 2026
Targeted Radionuclide Tumor Therapy: Biological Aspects
84% match

Targeted Radionuclide Tumor Therapy: Biological Aspects

Springer

£130.93 20 May 2026
Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy (Imaging in Medical Diagnosis and Therapy)
82% match

Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy (Imaging in Medical Diagnosis and Therapy)

CRC Press

£73.44 01 Jul 2026
Increasing the Therapeutic Ratio of Radiotherapy (Cancer Drug Discovery and Development)
81% match

Increasing the Therapeutic Ratio of Radiotherapy (Cancer Drug Discovery and Development)

Humana

£104.85 29 May 2026
Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)
81% match

Modification of Radiation Response: Cytokines, Growth Factors and Other Biological Targets (Medical Radiology / Diagnostic Imaging)

Springer

£53.53 16 May 2026
Nuclear Oncology
81% match

Nuclear Oncology

Springer

£114.89 06 Jun 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
81% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£111.46 31 May 2026
Bispecific Antibodies
81% match

Bispecific Antibodies

Springer

£129.06 11 Jun 2026
Radiation Therapy Physics (Medical Radiology)
80% match

Radiation Therapy Physics (Medical Radiology)

Springer

£77.55 24 Jun 2026
Nanoscale Insights into Ion-Beam Cancer Therapy
80% match

Nanoscale Insights into Ion-Beam Cancer Therapy

Springer

£109.14 24 Jun 2026
Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide
80% match

Radiation Therapy in Hematologic Malignancies: An Illustrated Practical Guide

Springer

£98.27 06 Jun 2026
Stereotactic Body Radiation Therapy: Principles and Practices
80% match

Stereotactic Body Radiation Therapy: Principles and Practices

Springer

£73.10 05 Jun 2026
Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)
80% match

Advances in Tumor Immunology and Immunotherapy (Current Cancer Research)

Springer

£108.92 10 Jun 2026
Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)
80% match

Immunotherapy of Cancer: Methods and Protocols: 651 (Methods in Molecular Biology, 651)

Humana

£103.24 25 May 2026
Immunotherapy for Gastrointestinal Cancer
80% match

Immunotherapy for Gastrointestinal Cancer

Springer

£99.03 05 Jun 2026
Radiotherapy in Managing Brain Metastases: A Case-Based Approach
80% match

Radiotherapy in Managing Brain Metastases: A Case-Based Approach

Springer

£73.10 05 Jun 2026
Molecular Imaging in Oncology: 187 (Recent Results in Cancer Research, 187)
80% match

Molecular Imaging in Oncology: 187 (Recent Results in Cancer Research, 187)

Springer

£125.53 24 May 2026
Immunotherapy for Pediatric Malignancies
80% match

Immunotherapy for Pediatric Malignancies

Springer

£113.90 05 Jun 2026
Radiation Toxicity: A Practical Medical Guide: 128 (Cancer Treatment and Research, 128)
80% match

Radiation Toxicity: A Practical Medical Guide: 128 (Cancer Treatment and Research, 128)

Springer

£128.29 24 May 2026
Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)
80% match

Basic and Clinical Tumor Immunology: 14 (Cancer Treatment and Research, 14)

Springer

£164.68 03 Jun 2026
Prevention and Management of Acute and Late Toxicities in Radiation Oncology: Management of Toxicities in Radiation Oncology
80% match

Prevention and Management of Acute and Late Toxicities in Radiation Oncology: Management of Toxicities in Radiation Oncology

Springer

£65.57 03 Jul 2026
Intensity Modulated Radiation Therapy. A Clinical Perspective
80% match

Intensity Modulated Radiation Therapy. A Clinical Perspective

£81.99 24 Jun 2026
Radiation Oncology Advances: 139 (Cancer Treatment and Research, 139)
80% match

Radiation Oncology Advances: 139 (Cancer Treatment and Research, 139)

Springer

£80.66 04 Jul 2026
Radiation Oncology Advances: 139 (Cancer Treatment and Research, 139)
80% match

Radiation Oncology Advances: 139 (Cancer Treatment and Research, 139)

Springer

£84.32 03 Jul 2026